Sanofi is reviewing operations at two of its factories that make vaccines in India and intends to lay off all workers at the facilities after it failed to win a UNICEF contract, Reuters’ Leroy Leo reports. The company told Reuters in an email that it is offering voluntary retirement scheme to all its employees at the two plants near Hyderabad. Reference Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on SNY:
- Regeneron, Sanofi announce EC expansion of Dupixent marketing authorization
- Regeneron, Sanofi announce CHMP opinion recommending EU approval for Dupixent
- Denali Therapeutics announces achievement of RIPK1 milestone for Phase 2 trial
- Innate Pharma announces HSR clearance for Sanofi collaboration expansion
- CytoReason to license IBD disease model to Sanofi